LEXINGTON, Mass. (AP) 鈥� LEXINGTON, Mass. (AP) 鈥� Voyager Therapeutics Inc. (VYGR) on Thursday reported a loss of $24.5 million in its second quarter.
The Lexington, Massachusetts-based company said it had a loss of 40 cents per share.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 55 cents per share.
The gene therapy company posted revenue of $3.2 million in the period, which fell short of Street forecasts. Three analysts surveyed by Zacks expected $3.5 million.
_____
This story was generated by (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a at https://www.zacks.com/ap/VYGR
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
